Related Experiment Video
Updated: Dec 25, 2025

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
ALBI versus child-pugh in predicting outcome of patients with HCC: A systematic review
Ying Peng1,2, Qinglin Wei1,2, Yonghong He1,2
1Cholestatic Liver Diseases Center and Department of Gastroenterology, Southwest Hospital, Third Military Medical University (Army Medical University) , Chongqing, China.
Insights
The albumin-bilirubin (ALBI) score demonstrates superior ability in predicting outcomes for hepatocellular carcinoma (HCC) patients compared to the Child-Pugh score. Further research is needed to enhance prognostic accuracy for HCC.
Area of Science:
- Hepatology
- Oncology
- Biomarker Research
Background:
- Hepatocellular carcinoma (HCC) is a highly aggressive cancer with a poor patient prognosis.
- The albumin-bilirubin (ALBI) score and Child-Pugh score are established tools for assessing prognosis in liver disease patients.
- Comparing the prognostic predictive power of ALBI and Child-Pugh scores in HCC is crucial for clinical decision-making.
Purpose of the Study:
- To systematically review and compare the prognostic discriminative ability of the ALBI score versus the Child-Pugh score in patients with hepatocellular carcinoma.
- To evaluate the current effectiveness of these scoring systems in predicting HCC patient outcomes.
Main Methods:
- A systematic literature search was conducted across major databases: PubMed, EMBASE, and Cochrane Library.
- Relevant studies comparing the prognostic abilities of ALBI and Child-Pugh scores in HCC patients were identified and data extracted.
- The extracted data were analyzed to assess the comparative predictive performance of the two scoring systems.
Main Results:
- The systematic review indicated that the ALBI score possesses superior discriminative ability compared to the Child-Pugh score for predicting prognosis in HCC patients.
- Despite ALBI's better performance, the overall predictive accuracy of both scores requires improvement for clinical utility.
- The study highlights the need for more refined prognostic indicators in HCC management.
Conclusions:
- The ALBI score is a more effective prognostic predictor than the Child-Pugh score in hepatocellular carcinoma.
- Advanced genomic and molecular techniques, such as sequencing and methylation analysis, offer potential for discovering novel HCC biomarkers.
- Future research should focus on validating new prognostic tools through multicenter prospective studies for early diagnosis and improved prognosis of HCC.
Introduction:
Hepatocellular carcinoma (HCC) is an aggressive tumor type which results in poor prognosis. ALBI and Child-Pugh score have been widely applied for predicting prognosis in patients with liver diseases. We conducted a systematic review to compare the prognostic ability of ALBI versus Child-Pugh in HCC patients.
Areas Covered:
PubMed, EMBASE and Cochrane Library were explored. The data were extracted from every study. Studies investigating HCC patients and comparing the predicting ability between ALBI and Child-Pugh were analyzed.
Expert Opinion:
This systematic review revealed that ALBI showed better discriminative ability than Child-Pugh for predicting the prognosis in HCC patients. However, the predictive abilities of two scores should be improved. Except for the most common used serum biomarker AFP for diagnosis and surveillance of HCC, recent studies have also explored all aspects of HCC through genome-wide sequencing, exome sequencing, RNA sequencing and genome-wide methylation analysis which provide essential clues for genotyping of HCC. Further studies should explore biomarkers by advanced techniques to validate new prognostic tools for early diagnosis and prognosis of HCC. Moreover, multicenter prospective studies should be carried out to compare the prognostic values of predictive indicators in HCC population in the future.
More Related Videos
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Comparing the Survival Analysis of Two or More Groups
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

